Guggenheim analyst Subbu Nambi initiates coverage on Repligen (NASDAQ:RGEN) with a Neutral rating.
Guggenheim Initiates Coverage On Repligen With Neutral Rating
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.